In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ardian: Succeeding Where Drugs Fail--Treating Hypertension in the Cath Lab

Executive Summary

Using the first catheter therapy for the interventional treatment of hypertension, this start-up's technology may be able to reduce blood pressure where drugs have not worked, and holds future promise for heart failure and kidney disease.
Advertisement

Related Content

Renal Denervation Sparks Device Market Gold Rush
Miramar Labs: Bringing A Traditional Device Model To Aesthetics
Proving Device Incubation Works: An Interview with The Foundry
Masterminds of Ardian: An Interview With Inventors Mark Gelfand and Howard Levin
Device M&A Rebound Continues: With Ardian, Sadra Deals Show Appetite For Big, Early-Stage Acquisitions
Dealmaking in 2009: A Look Back and A Glance Ahead
Top Device Stories of 2009: A Year of Economic Revival and Regulatory Risk
CVRx: Can Devices Succeed Where Drugs Fail for High Blood Pressure?
CVRx: Can Devices Succeed Where Drugs Fail for High Blood Pressure?
The Cardio-Renal Connection

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV003211

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel